Alethia Young - 06 Sep 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Director
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Issuer symbol
PTCT
Transactions as of
06 Sep 2023
Net transactions value
-$464,972
Form type
4
Filing time
08 Sep 2023, 16:02:43 UTC
Previous filing
19 Jul 2023
Next filing
11 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Options Exercise $194,950 +7,000 +77% $27.85 16,067 06 Sep 2023 Direct
transaction PTCT Common Stock Sale $279,300 -7,000 -44% $39.90 9,067 06 Sep 2023 Direct
transaction PTCT Common Stock Options Exercise $129,948 +4,666 +51% $27.85 13,733 06 Sep 2023 Direct
transaction PTCT Common Stock Sale $185,672 -4,666 -34% $39.79 9,067 06 Sep 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTCT Stock Option (Right to Buy) Options Exercise $194,950 -7,000 -100% $27.85 0 06 Sep 2023 Common Stock 7,000 $27.85 Direct F2
transaction PTCT Stock Option (Right to Buy) Options Exercise $129,948 -4,666 -39% $27.85 7,334 06 Sep 2023 Common Stock 4,666 $27.85 Direct F3
holding PTCT Stock Option (Right to Buy) 10,000 06 Sep 2023 Common Stock 10,000 $39.42 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $39.77 to $39.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F2 Currently exercisable.
F3 This option was granted on June 9, 2022 and vests over thirty-six approximately equal monthly installments, commencing on July 8, 2022
F4 This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023.